Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies

PLoS Pathogens(2025)10.1371/journal.ppat.1012428Source: DataRank Database

Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies is a research paper published in PLoS Pathogens (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 2.04)OA: goldTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Filip Popovic,Christina Holmboe Olesen ORCID,Blanca López‐Méndez ORCID,Brian Lohse ORCID,Zhaochun Chen

Live enrichment

PubMed:40153382 PMC:PMC11999149 OpenAlex:https://openalex.org/W4408937385

Lundbeck Foundation

Grant: R324-2019-1375

Lundbeck Foundation

Grant: R335-2019-2052

Novo Nordisk Fonden

Grant: NNF19OC0054518

Novo Nordisk Fonden

Grant: NNF23OC0087091

Novo Nordisk Fonden

Grant: NNF19OC0055462

Danmarks Frie Forskningsfond

Grant: 4004-00598B

Novo Nordisk Fonden

Grant: NNF170C0026778

Candys Foundation

Grant: 2019-317

Candys Foundation

Grant: 2023-437

Novo Nordisk Foundation

Grant: unidentified

unidentified

Mauritzen La Fontaine Foundation

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

FWCI

2.04

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1012428&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1012428&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1012428

journalhttps://doi.org/10.1371/journal.ppat.1012428

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40153382

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchHepatitis C virus researchProtein purification and stabilityHumansHepacivirusViral Envelope ProteinsHepatitis C AntibodiesAntibodies, NeutralizingEpitopesHepatitis C

MeSH Terms

EpitopesHepatitis CHumansViral Envelope ProteinsHepacivirusHepatitis C AntibodiesAntibodies, Neutralizing

Keywords

VirologyAntibodyNeutralizing antibodySelection (genetic algorithm)BiologyImmunologyComputer scienceEpitopesViral Envelope ProteinsQH301-705.5HumansHepacivirusImmunologic diseases. AllergyRC581-607Biology (General)Hepatitis C AntibodiesAntibodies, NeutralizingHepatitis CResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being

Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies

FAIR Checklist

Authors (12)

Funding (12 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)